After seven people have gotten sick with meningitis B since March, the CDC is working on importing a vaccine that received approval in Europe but not in the US yet:
Under the plan, all undergraduate students, graduate students living in dormitories, and members of the university community with certain vulnerable conditions would be advised to receive vaccinations to protect against serogroup B meningitis, which is missing from the shots already recommended for U.S. college students.
The move follows a request by the Centers for Disease Control in October to import emergency doses of the vaccine Bexsero, made by Novartis, and approved in Europe and Australia, but not in the U.S.
"Pending final CDC approval, the University is prepared to accept these recommendations and make arrangements to provide access to this vaccine as soon as possible," Princeton officials said in a statement.
School officials said they hoped to make the first of two doses of the vaccine available in early December, with a second dose in February. Six Princeton students and a student visitor have contracted the infection since March, including a male student who was hospitalized on Nov. 10. All have recovered or are recovering, officials said.
What do you think about them using a vaccine that hasn't been licensed in the US?